ROYAL BANK OF CANADA - MINK THERAPEUTICS INC ownership

MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 22 filers reported holding MINK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MINK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,0000.0%649
+20.6%
0.00%
Q2 2023$1,000538
+393.6%
0.00%
Q1 2023$0
-100.0%
109
-52.0%
0.00%
Q4 2022$1,0000.0%227
-51.5%
0.00%
Q3 2022$1,000468
+277.4%
0.00%
Q1 2022$0
-100.0%
124
-74.4%
0.00%
Q4 2021$2,0004850.00%
Other shareholders
MINK THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 345,499$1,541,0000.09%
Artal Group S.A. 289,588$1,292,0000.04%
Gyon Technologies Capital Management, LP 42,448$189,0000.04%
RTW INVESTMENTS, LP 416,666$1,858,0000.03%
VANGUARD GROUP INC 10,771$48,0000.00%
Ameritas Investment Partners, Inc. 150$1,0000.00%
UBS Group AG 3,934$18,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 1,037$5,0000.00%
BANK OF AMERICA CORP /DE/ 1,847$8,0000.00%
WELLS FARGO & COMPANY/MN 1,207$5,0000.00%
View complete list of MINK THERAPEUTICS INC shareholders